Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Compiegne – page 3

29 clinical trials in Compiegne, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Compiegne at a glance
29
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

29 trials in Compiegne

Open in trial search

Arteriosclerosis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Olema Pharmaceuticals Inc.

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Compiegne

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on colorectal cancer, breast cancer, and renal cell carcinoma treatments. Studies evaluate innovative therapeutic approaches including targeted therapies and immunotherapy combinations.

  • Advanced Colorectal Treatments
  • Triple-Negative Breast Cancer
  • Metastatic Cancer Management

Particular emphasis on personalized treatment approaches and circulating tumor DNA analysis for treatment decisions.

02 Cardiovascular Studies

Innovative research targeting atherosclerotic cardiovascular disease and related conditions. Trials evaluate new therapeutic agents for reducing cardiovascular events and managing risk factors.

  • Lipoprotein Management
  • Primary Prevention Strategies
  • Advanced Cardiovascular Therapeutics

Focus on preventive measures and novel treatments for high-risk cardiovascular patients.

03 Infectious Disease Research

Studies investigating treatments for Mycobacterium infections and related pulmonary conditions. Evaluation of innovative antibiotic therapies and treatment protocols.

  • Pulmonary Infections
  • Antibiotic Efficacy Studies
  • Treatment Protocol Optimization

Emphasis on comparing different therapeutic approaches for better patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.